About Cyno Pharmaceuticals Limited
Data last updated:
Cyno Pharmaceuticals Limited is a public limited company based in Bharatpur, Rajasthan, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 28 October 1993 and has been in existence for over 33 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U24232RJ1993PLC007771.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Sanjay Jain and Madhu Jain.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at F – 27 RIICO Industrial Area, Bharatpur, Rajasthan, India – 321001.
As per the financials filed for FY 2024, the company reported a revenue of ₹20,960. For the same year it recorded a net loss of ₹22,145 (net margin -105.7%) and EBITDA of -₹22,145 (EBITDA margin -105.7%).
The company is associated with 1 brand: CYNO Pharmaceuticals. As per MCA filings, the company has satisfied charges of ₹6 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website cyno.co.in.
Company details
Contact details
Cyno Pharmaceuticals Limited's registered office is in Bharatpur, Rajasthan. Its website is cyno.co.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressF – 27 RIICO Industrial Area, Bharatpur, Rajasthan, India – 321001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Cyno Pharmaceuticals Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Cyno Pharmaceuticals operates one associated brand: CYNO Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Specialty pharmaceutical manufacturing and contract services with a focus on drug improvement. | cyno.co.in |
Financials of Cyno Pharmaceuticals Limited
FY 2025 filings availableCyno Pharmaceuticals Limited reported revenue of ₹20,960 for FY 2024.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹20,960 | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹22,145 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹22,145 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -105.7% | ||||
| Net Profit Margin | -105.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Cyno Pharmaceuticals Limited, buy the company report.
Board of directors of Cyno Pharmaceuticals Limited
Cyno Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sanjay Jain Also directs: Cyno Pharmaceuticals Limited, Eqova Finance Private Limited, Cyno Lifesciences Private Limited and 5 more | Director | 28 Sep 1998 | 28 Years 0 Months | Current |
| Madhu Jain Also directs: Cyno Pharmaceuticals Limited, Eqova Finance Private Limited, Cyno Lifesciences Private Limited and 1 more | Director | 08 Oct 1998 | 28 Years 0 Months | Current |
| Rajendra Singh Also directs: Cyno Pharmaceuticals Limited, Eqova Infrastructures Private Limited, Eqova Medicare Private Limited and 2 more | Director | 08 Oct 1998 | 28 Years 0 Months | Current |
Peer comparison
Cyno Pharmaceuticals Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Zephyros Pharmaceuticals Private Limited | ₹21,190 (FY 2024) | -98.0% | Chandigarh, India | |||
| Alliant Lifesciences Private Limited | ₹21,032 (FY 2023) | -95.0% | Mumbai, Maharashtra, India | |||
| Yashvi Pharma Private Limited | ₹21,000 (FY 2025) | Ahmedabad, Gujarat, India | ||||
| Vardhaman Laboratories Limited | ₹21,000 (FY 2025) | -90.0% | Sangli, Maharashtra, India | |||
| Spinzer Pharmaceuticals Private Limited | ₹20,988 (FY 2024) | -5.0% | New Delhi, Delhi, India | |||
| Cyno Pharmaceuticals Limitedthis company | ₹20,960 (FY 2024) | -₹22,145 | -105.7% | Bharatpur, Rajasthan, India | ||
| Ashoka Pesticide and Chemical Industries Pvt Ltd | ₹20,890 (FY 2024) | -100.0% | Alwar, Rajasthan, India | |||
| Mykom Laboratories Private Limited | ₹20,788 (FY 2025) | Delhi, India | ||||
| Biocius Pharmaceuticals Private Limited | ₹20,469 (FY 2025) | -58.0% | Harinagar, Delhi, India | |||
| VL Infratech Services Private Limited | ₹20,443 (FY 2025) | -99.0% | Guwahati, Assam, India | |||
| Glacus Healthcare Limited | ₹20,251 (FY 2020) | Ahmedabad, Gujarat, India |
To see the full peer comparison of Cyno Pharmaceuticals Limited, buy the company report.
Auditor
Cyno Pharmaceuticals Limited is audited by GARG RAJENDRA & CO. for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GARG RAJENDRA & CO. | FY 2024 | 006441C |
Shareholding
The shareholding of Cyno Pharmaceuticals Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Cyno Pharmaceuticals Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 18 Sep 1999 | 90258532 | Punjab National Bank | ₹6 Lakh | Satisfied |
To see the full charge records of Cyno Pharmaceuticals Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Cyno Pharmaceuticals Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Cyno Pharmaceuticals Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Cyno Pharmaceuticals Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Cyno Pharmaceuticals Limited has 4 board changes on record since 1998: 3 appointments and 1 cessation. The latest: Nirmal Singh ceased to be Director on 22 Jun 2018.
Frequently asked questions
Cyno Pharmaceuticals is an active public limited company based in Bharatpur, Rajasthan, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 28 October 1993 (33+ years old) and is registered under CIN U24232RJ1993PLC007771.
Cyno Pharmaceuticals has 3 current directors:
- Sanjay Jain - Director
- Madhu Jain - Director
- Rajendra Singh - Director
The latest financial statements of Cyno Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Cyno Pharmaceuticals is U24232RJ1993PLC007771. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cyno Pharmaceuticals was incorporated on 28 October 1993, making it 33+ years old. It is registered with the Registrar of Companies, Jaipur.
The peers of Cyno Pharmaceuticals by revenue are Zephyros Pharmaceuticals Private Limited, Alliant Lifesciences Private Limited, Yashvi Pharma Private Limited, Vardhaman Laboratories Limited, Spinzer Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).
Nirmal Singh ceased to be Director on 22 Jun 2018. Madhu Jain was appointed as Director on 08 Oct 1998. Rajendra Singh was appointed as Director on 08 Oct 1998. Cyno Pharmaceuticals has 4 board changes on record in total.
Cyno Pharmaceuticals can be reached through the website cyno.co.in. Its registered office is in Bharatpur, Rajasthan, India.
The registered office of Cyno Pharmaceuticals is at F – 27 RIICO Industrial Area, Bharatpur, Rajasthan, India – 321001.
Cyno Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Cyno Pharmaceuticals has no open charges and satisfied charges of ₹6 Lakh as per latest MCA filings.